Look behind the lecture: the current and future states of patient-centered pharmacovigilance
In this interview, Brian Edwards, (NDA Regulatory Science Ltd, Surrey, UK), discusses his presentation from the 2019 Drug Information Association Annual Meeting (23–27 June; CA, USA) on the importance of accurate and precise pharmacovigilance and how patient engagement may contribute to the future improvement of this. Please can you introduce yourself and your institution? I am a Principal Consultant in pharmacovigilance and drug safety with NDA Regulatory Science Ltd (Surrey, UK). I am also a Board Member of the International Society of Pharmacovigilance (London, UK) and Chair of the Pharmaceutical Human Factors and Ergonomics Group (Chartered Institute of Ergonomics and...